Sector portfolio · Investment bank · China
CICC's Biotech portfolio
CICC has backed 12 Biotech startups in rounds we track, $676M between them, shown by the stage each has reached. The best-funded is Asieris Pharmaceuticals.
Funding by segment
- Series B$309M6
- Series A$61M2
- Stage not reported$114M2
- Series C and later$192M2
Where they are based
- China10$597M
- United States1$65M
China
United StatesFounded
5 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M5
- $50M to $250M7
- $250M to $1B0
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
7 of 12 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- China10
- United States1
Startups by country, 2 countries in all.
Segment by segment
Series B
6 startups · $309M raised
- RRimagRimag is a Shenzhen-based medical imaging service provider.China$108M
Singlera GenomicsSinglera Genomics is a fast growing company focusing on non-invasive genetic testing.United States$65M
Tsingke BiotechTsingke Biotech, officially known as Beijing Tsingke Biotech Co., Ltd., is a leading biotechnology company based in Beijing, China.China$58M- LLachesisChina$51M
Yaohai BioYaohai Bio is a genetic engineering protein drug developerChina$14MRaisecareRaisecare conducts life science research, manufactures and sells life science goods, and develops vitro diagnostic tools.China$14M
Series A
2 startups · $61M raised
- BBiOligoBioligo establishes and provides high-quality DNA synthesis/sequencing, experiments, production and various customized services.China$47M
- CCholesgenCholesgen is a biopharmaceutical company dedicated to developing innovative drugs.China$14M
Stage not reported
2 startups · $114M raised
- ZZhangshangtangyiChina$100M
- KBKejin BiotechnologyKejin Biotechnology develops high-end laboratory consumables and underlying novel materials that are monopolized by imports.-$14M
Series C and later
2 startups · $192M raised
Asieris PharmaceuticalsAsieris Pharmaceuticals is a Chinese biotech company.China$121M
GenetronGenetron sells test and measurement equipment.China$71M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names CICC as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like CICC?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.